The Johnson & Johnson’s vaccine’s efficacy rate dropped from 72 percent in the United States to just 57 percent in South Africa, where a highly contagious variant is driving most cases.
— NYT: Top Stories
Tag: Johnson & Johnson
Johnson & Johnson plans to enroll 60,000 participants in its Phase 3 trials. Dr. Anthony Fauci and other top U.S. health officials are scheduled to testify before a Senate panel today.
— NYT: Top Stories